ArticleClinical rheumatology2023

Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.